Clin Tox DOA committee
Chair: O.Drummer (olaf@vifm.org)
Vice Chair: Vanessa Steenkamp (vanessa.steenkamp@up.ac.za)
Report of recent activities
- The committee last met at the Montreal meeting.
- The clinical toxicology committee set up a working group to produce guidelines on clinical cut-offs for drugs of abuse in cases of child abuse, psychiatric patients and pregnant women.
- The committee established a working party on guidelines for identification using LC-MS(MS) led by Dr Frank Peters.
- The committee commissioned a paper on GHB by Professor Drummer. A draft has been circulated to committee for review. Dr André Scholer has written an article on methylphenidate.
- Professor Steven Wong is progressing his work on personalized justice and pharmacogenomics. Meetings have been held. The committee is briefed from to time on its activities.
- The committee has been requested to submit ideas for workshops and symposia/roundtables for the Stuttgart meeting next year.
- Dr William Clarke (Baltimore, USA), Dr Gwendolyn McMillin (Utah, USA) and Dr Manuel Neuman (Toronto, Canada) have joined the committee after invitation.
- The committee chair through the committee will suggest a deputy chair for approval at Executive.
Olaf H Drummer
Chair, Clinical Toxicology/Drugs of Abuse Committee
April, 2010
Minutes of the committee meeting held in Montreal on October 7th, 2009 (PDF): accessible to Members only (committee reports page)
Scientific contributions of the Committee:
- Six clinical cases used in the Dutch QA Scheme
- "Clinical Toxicology/Drugs of Abuse" : The North American Oxycodone Story 2001-2002
- Therapeutic Drug Monitoring of high-dose buprenorphine: why and how?
- The Effect of Urine Manipulation on Substance Abuse Testing
Terms of reference
To promote and advance the discipline of Clinical Toxicology within the Association by:
1. Developing relevant practice guidelines, when appropriate, in particular fields of clinical toxicology and drugs of abuse testing;
2. Publishing articles and other professional notes in the field of clinical toxicology and drugs of abuse in the Newsletter and on the web page;
3. Assist in the holding of specialist workshops and symposia at the biennial Association meetings;
4. Developing links and partnerships with other relevant professional societies; and
5. Attracting new members to the Association with interests in clinical toxicology and drugs of abuse;
Members
Chair: Professor Dr. Olaf Drummer, olaf@vifm.org
Professor Dr. Albert Fraser, adfraser@dal.ca
Professor Dr. Marilyn A. Huestis, mhuestis@intra.nida.nih.gov
Dr. Saeed A. Jortani, sjortani@Louisville.edu
Dr. Pascal Kintz, pascal.kintz@wanadoo.fr
Professor Dr. Tai C. Kwong, tai_kwong@urmc.rochester.edu
Professor Dr. Hans H. Maurer, hans.maurer@uks.eu
Dr. Katharina Rentsch, rentsch@ikc.unizh.ch
Dr. André Scholer, ascholer@uhbs.ch
Professor Dr. Donald Uges, d.r.a.uges@apoth.umcg.nl
Professor Dr. Alain Verstraete, Alain.Verstraete@ugent.be
Professor Dr. Robert Wennig, robert.wennig@uni.lu
Dr. John F. Wilson, heathcontrol@btinternet.com
Professor Dr. Steven Wong, shwong@mcw.edu
Dr Loralie Langman, langman.loralie@mayo.edu
Dr Vanessa Steenkamp, vanessa.steenkamp@up.ac.za
Dr Frank Peters, frank.peters@med.uni-jena.de
Dr William Clarke, wclarke@jhmi.edu
Dr Gwendolyn McMillin, mcmillga@aruplab.com
Dr Manuela Neuman, manuela.neuman@utoronto.ca